The value-for-money assessment and funding arrangements for high-priced drugs in an era of uncertainty: a comparative analysis of national health technology assessment agencies in South Korea, England, Australia, and Canada.
Saved in:
| Title: | The value-for-money assessment and funding arrangements for high-priced drugs in an era of uncertainty: a comparative analysis of national health technology assessment agencies in South Korea, England, Australia, and Canada. |
|---|---|
| Authors: | Hong J; Department of Healthcare Management, Gachon University, Seongnam-Si, Gyeonggi-Do, Republic of Korea., Bae EY; College of Pharmacy, Gyeongsang National University, 501 Jinju-Daero, Jinju, 52828, Republic of Korea. eybae@gnu.ac.kr., Cha S; College of Pharmacy, Gyeongsang National University, 501 Jinju-Daero, Jinju, 52828, Republic of Korea., Lee J; College of Pharmacy, Gyeongsang National University, 501 Jinju-Daero, Jinju, 52828, Republic of Korea. |
| Source: | BMC health services research [BMC Health Serv Res] 2025 Jan 14; Vol. 25 (1), pp. 74. Date of Electronic Publication: 2025 Jan 14. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
